Hereditary Hemorrhagic Telangiectasia in Pediatric Age: Focus on Genetics and Diagnosis
Hereditary Hemorrhagic Telangiectasia (HHT) or Rendu–Osler–Weber Syndrome (ROW) is an autosomal dominant vascular disease, with an estimated prevalence of 1:5000. Genes associated with HHT are <i>ACVRL1</i>, <i>ENG</i>, <i>SMAD4</i>, and <i>GDF2</i>, a...
Main Authors: | Cesare Danesino, Claudia Cantarini, Carla Olivieri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Pediatric Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2036-7503/15/1/11 |
Similar Items
-
Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
by: John M. Lee, et al.
Published: (2019-10-01) -
Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management
by: Ole Jakob Jørgensen, et al.
Published: (2024-02-01) -
A case of hereditary hemorrhagic telangiectasia presenting with brain abscess
by: Marwa Zeyad, et al.
Published: (2023-09-01) -
Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia
by: K. P. Thompson, et al.
Published: (2022-11-01) -
Hereditary Hemorrhagic Telangiectasia - a literature review
by: Marcel Stodolak, et al.
Published: (2024-04-01)